Attitudes regarding polygenic risk testing for lung cancer: a mixed-methods study
Annals of Behavioral Medicine · 2025
DOI: 10.1093/abm/kaaf020 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Annals of Behavioral Medicine, 2025. Verfasst von Hoda Badr und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Baylor College of Medicine, Houston, TX, United States. Hauptthemen laut MEDLINE: Lung Neoplasms, Health Knowledge, Attitudes, Practice, Genetic Testing, Genetic Predisposition to Disease. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDA NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Polygenic risk scores (PRS) hold promise for early lung cancer detection and personalized treatment, yet factors influencing patient interest in PRS-based genetic testing are not well understood.
Purpose
Grounded in the health belief model, this mixed-methods study explored knowledge, attitudes, perceived benefits and barriers to lung cancer PRS, and preferences for receiving PRS results.
Results
The study included 141 individuals (41% African American, 63% female) recruited from two hospital affiliates of a comprehensive cancer center in the Southwestern United States. Although participants recognized the severity of lung cancer, knowledge of PRS was limited. Concerns about privacy, psychological impacts, and uncertainty about result usefulness diminished interest in genetic testing for polygenic risk. Significant differences (P < .05) in attitudes were observed: women expressed heightened concerns about psychological effects, and African Americans reported greater perceptions of stigma and concerns about potential familial consequences. Qualitative findings emphasized the psychological burden of learning one’s genetic risk, particularly among those with family cancer histories or smoking exposure. Participants emphasized the need for clear, actionable results and assurances of data privacy.
Conclusions
Perceived benefits and barriers to PRS-based testing varied by sociodemographic and personal risk factors, with concerns about stigma, psychological burden, and privacy shaping attitudes. Given participants’ emphasis on clear, actionable results, strategies to enhance uptake should improve risk communication, ensure data privacy, and provide guidance on risk-reducing actions. Tailored approaches addressing subgroup-specific concerns may improve diverse patient engagement and equitable access to PRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Baylor College of Medicine, Houston, TX, United States.
- University of New Mexico Comprehensive Cancer Center, Albequerque, NM, United States.
- Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
ORCID-Profile: Hoda Badr
Förderung
- NCI NIH HHS
- NIDA NIH HHS
- National Cancer Institute
Zitieren
APA
Badr, H., Byun, J., Aldrich, M. C., Bierut, L. J., Chen, L. S., Hung, R. J., & Amos, C. I. (2025). Attitudes regarding polygenic risk testing for lung cancer: a mixed-methods study. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/kaaf020
Vancouver
Badr H, Byun J, Aldrich MC, Bierut LJ, Chen LS, Hung RJ, et al. Attitudes regarding polygenic risk testing for lung cancer: a mixed-methods study. Annals of Behavioral Medicine. 2025. doi:10.1093/abm/kaaf020
BibTeX
@article{Badr2025,
author = {Badr, Hoda and Byun, Jinyoung and Aldrich, Melinda C and Bierut, Laura J and Chen, Li-Shiun and Hung, Rayjean J and Amos, Christopher I},
title = {Attitudes regarding polygenic risk testing for lung cancer: a mixed-methods study},
journal = {Annals of Behavioral Medicine},
year = {2025},
doi = {10.1093/abm/kaaf020}
}
EUVIMED